- Home
- WSBF vs ALDX Comparison
WSBF vs ALDX Comparison
Compare WSBF & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WSBF | ALDX |
|---|---|---|
| Founded | 1921 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 312.7M | 293.0M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | WSBF | ALDX |
|---|---|---|
| Price | $17.50 | $5.54 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.50 |
| AVG Volume (30 Days) | 44.0K | ★ 836.4K |
| Earning Date | 01-26-2026 | 02-27-2026 |
| Dividend Yield | ★ 3.42% | N/A |
| EPS Growth | ★ 87.32 | N/A |
| EPS | ★ 1.32 | N/A |
| Revenue | ★ $137,060,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $36.25 |
| P/E Ratio | $13.26 | ★ N/A |
| Revenue Growth | ★ 2.87 | N/A |
| 52 Week Low | $11.61 | $1.14 |
| 52 Week High | $18.61 | $7.20 |
Technical Indicators
Market Signals| Indicator | WSBF | ALDX |
|---|---|---|
| Relative Strength Index (RSI) | 59.01 | 65.70 |
| Support Level | $17.24 | $5.05 |
| Resistance Level | $18.61 | $5.43 |
| Average True Range (ATR) | 0.44 | 0.31 |
| MACD | 0.02 | 0.14 |
| Stochastic Oscillator | 52.09 | 93.84 |
Price Performance
Historical ComparisonAbout WSBF Waterstone Financial Inc. (MD)
Waterstone Financial Inc is a holding company. Through its subsidiaries, it operates in two reportable segments: Community Banking and Mortgage Banking. The Community Banking segment provides consumer and business banking products and services to customers, which include various types of loans, deposits, and personal investment services. The Mortgage Banking segment involves residential mortgage loans for the primary purpose of sale in the secondary market. The vast majority of its revenue comes from the Community Banking segment.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.